nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergoloid mesylate—SLCO2B1—Niacin—atherosclerosis	0.319	0.335	CbGbCtD
Ergoloid mesylate—SLCO2B1—Rosuvastatin—atherosclerosis	0.271	0.285	CbGbCtD
Ergoloid mesylate—SLCO2B1—Pravastatin—atherosclerosis	0.247	0.259	CbGbCtD
Ergoloid mesylate—CYP3A4—Rosuvastatin—atherosclerosis	0.0241	0.0253	CbGbCtD
Ergoloid mesylate—CYP3A4—Ezetimibe—atherosclerosis	0.0241	0.0253	CbGbCtD
Ergoloid mesylate—CYP3A4—Simvastatin—atherosclerosis	0.0224	0.0235	CbGbCtD
Ergoloid mesylate—CYP3A4—Pravastatin—atherosclerosis	0.0219	0.023	CbGbCtD
Ergoloid mesylate—CYP3A4—Lovastatin—atherosclerosis	0.0219	0.023	CbGbCtD
Ergoloid mesylate—DRD2—Signaling by GPCR—CCL4—atherosclerosis	5.52e-05	0.00113	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—UTS2—atherosclerosis	5.42e-05	0.00111	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR ligand binding—AGT—atherosclerosis	5.27e-05	0.00107	CbGpPWpGaD
Ergoloid mesylate—DRD2—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	5.23e-05	0.00107	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—CASR—atherosclerosis	5.2e-05	0.00106	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—CCL3—atherosclerosis	5e-05	0.00102	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—CCR2—atherosclerosis	4.98e-05	0.00102	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—EDNRA—atherosclerosis	4.98e-05	0.00102	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—UTS2—atherosclerosis	4.92e-05	0.001	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR ligand binding—F2—atherosclerosis	4.87e-05	0.000993	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—GHRL—atherosclerosis	4.85e-05	0.000989	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—CNR2—atherosclerosis	4.83e-05	0.000986	CbGpPWpGaD
Ergoloid mesylate—DRD2—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	4.83e-05	0.000985	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR ligand binding—EDN1—atherosclerosis	4.79e-05	0.000978	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR ligand binding—CCL5—atherosclerosis	4.76e-05	0.00097	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—CX3CR1—atherosclerosis	4.72e-05	0.000963	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—CASR—atherosclerosis	4.72e-05	0.000963	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—APOA4—atherosclerosis	4.69e-05	0.000957	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—CX3CL1—atherosclerosis	4.63e-05	0.000944	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—CCR2—atherosclerosis	4.52e-05	0.000922	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—EDNRA—atherosclerosis	4.52e-05	0.000922	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—HRH1—atherosclerosis	4.51e-05	0.000921	CbGpPWpGaD
Ergoloid mesylate—DRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	4.51e-05	0.000919	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—GHRL—atherosclerosis	4.41e-05	0.000898	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—CNR2—atherosclerosis	4.39e-05	0.000895	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR ligand binding—CCL2—atherosclerosis	4.34e-05	0.000885	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—CCL4—atherosclerosis	4.32e-05	0.000882	CbGpPWpGaD
Ergoloid mesylate—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	4.3e-05	0.000878	CbGpPWpGaD
Ergoloid mesylate—DRD2—G alpha (i) signalling events—CXCL8—atherosclerosis	4.28e-05	0.000873	CbGpPWpGaD
Ergoloid mesylate—DRD2—Circadian rythm related genes—MAPK8—atherosclerosis	4.27e-05	0.00087	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—KNG1—atherosclerosis	4.26e-05	0.000868	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—AGTR1—atherosclerosis	4.23e-05	0.000863	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—APOA2—atherosclerosis	4.04e-05	0.000824	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR ligand binding—AGT—atherosclerosis	3.98e-05	0.000812	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—KNG1—atherosclerosis	3.87e-05	0.000789	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—UTS2—atherosclerosis	3.85e-05	0.000786	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—AGTR1—atherosclerosis	3.84e-05	0.000784	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	3.83e-05	0.000781	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	3.78e-05	0.000771	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—CCL3—atherosclerosis	3.77e-05	0.00077	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—CCR2—atherosclerosis	3.76e-05	0.000766	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—EDNRA—atherosclerosis	3.76e-05	0.000766	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—CX3CR1—atherosclerosis	3.69e-05	0.000753	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—CASR—atherosclerosis	3.69e-05	0.000753	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR ligand binding—F2—atherosclerosis	3.68e-05	0.00075	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—GHRL—atherosclerosis	3.66e-05	0.000747	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—CX3CL1—atherosclerosis	3.62e-05	0.000739	CbGpPWpGaD
Ergoloid mesylate—DRD1—Circadian rythm related genes—IL6—atherosclerosis	3.61e-05	0.000736	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—EDN1—atherosclerosis	3.59e-05	0.000732	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—CCL5—atherosclerosis	3.56e-05	0.000726	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—APOA4—atherosclerosis	3.54e-05	0.000722	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—CNR2—atherosclerosis	3.43e-05	0.0007	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR ligand binding—CXCL8—atherosclerosis	3.43e-05	0.0007	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—MMP3—atherosclerosis	3.43e-05	0.000699	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—CCR2—atherosclerosis	3.41e-05	0.000696	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—EDNRA—atherosclerosis	3.41e-05	0.000696	CbGpPWpGaD
Ergoloid mesylate—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	3.4e-05	0.000694	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—PRKCG—atherosclerosis	3.39e-05	0.00069	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—GHRL—atherosclerosis	3.33e-05	0.000678	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR ligand binding—CCL2—atherosclerosis	3.28e-05	0.000668	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CCL4—atherosclerosis	3.26e-05	0.000666	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—EDN1—atherosclerosis	3.26e-05	0.000665	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—CCL5—atherosclerosis	3.23e-05	0.000659	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—KNG1—atherosclerosis	3.21e-05	0.000656	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—AGTR1—atherosclerosis	3.2e-05	0.000652	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—PRKCG—atherosclerosis	3.07e-05	0.000627	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—VWF—atherosclerosis	3.06e-05	0.000624	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—APOA2—atherosclerosis	3.05e-05	0.000622	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—APOC3—atherosclerosis	3.04e-05	0.00062	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—LDLR—atherosclerosis	3.02e-05	0.000617	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—AGT—atherosclerosis	2.98e-05	0.000607	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—CCL3—atherosclerosis	2.95e-05	0.000602	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—KNG1—atherosclerosis	2.92e-05	0.000595	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—UTS2—atherosclerosis	2.91e-05	0.000593	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—AGTR1—atherosclerosis	2.9e-05	0.000592	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—NCF1—atherosclerosis	2.83e-05	0.000577	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CX3CR1—atherosclerosis	2.79e-05	0.000569	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CASR—atherosclerosis	2.79e-05	0.000569	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—F2—atherosclerosis	2.75e-05	0.000561	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CX3CL1—atherosclerosis	2.73e-05	0.000558	CbGpPWpGaD
Ergoloid mesylate—DRD2—Circadian rythm related genes—IL6—atherosclerosis	2.72e-05	0.000556	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	2.72e-05	0.000554	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—EDN1—atherosclerosis	2.71e-05	0.000553	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—AGT—atherosclerosis	2.7e-05	0.000552	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—CCL5—atherosclerosis	2.69e-05	0.000548	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—EDNRA—atherosclerosis	2.67e-05	0.000545	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—CCR2—atherosclerosis	2.67e-05	0.000545	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—CYBA—atherosclerosis	2.66e-05	0.000542	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—PIK3CG—atherosclerosis	2.63e-05	0.000537	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—PLAT—atherosclerosis	2.6e-05	0.000531	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—GHRL—atherosclerosis	2.6e-05	0.000531	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—PARP1—atherosclerosis	2.6e-05	0.000531	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CNR2—atherosclerosis	2.59e-05	0.000529	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR ligand binding—CXCL8—atherosclerosis	2.59e-05	0.000528	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—MMP3—atherosclerosis	2.59e-05	0.000528	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—PRKCG—atherosclerosis	2.56e-05	0.000521	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PLTP—atherosclerosis	2.55e-05	0.000521	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—F2—atherosclerosis	2.5e-05	0.00051	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—EDN1—atherosclerosis	2.46e-05	0.000502	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—CCL5—atherosclerosis	2.44e-05	0.000498	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—PIK3CG—atherosclerosis	2.39e-05	0.000488	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—PRKCG—atherosclerosis	2.32e-05	0.000473	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—VWF—atherosclerosis	2.31e-05	0.000471	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—APOC3—atherosclerosis	2.3e-05	0.000468	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—KNG1—atherosclerosis	2.28e-05	0.000466	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—LDLR—atherosclerosis	2.28e-05	0.000465	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—AGTR1—atherosclerosis	2.27e-05	0.000463	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—AGT—atherosclerosis	2.25e-05	0.000459	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CCL3—atherosclerosis	2.23e-05	0.000455	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—CCL2—atherosclerosis	2.23e-05	0.000454	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—ABCG8—atherosclerosis	2.21e-05	0.000452	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—LTA4H—atherosclerosis	2.21e-05	0.000452	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—PLG—atherosclerosis	2.21e-05	0.000451	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—NCF1—atherosclerosis	2.13e-05	0.000435	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—SOCS3—atherosclerosis	2.1e-05	0.000427	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—F2—atherosclerosis	2.08e-05	0.000424	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—AGT—atherosclerosis	2.04e-05	0.000416	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—MMP3—atherosclerosis	2.02e-05	0.000413	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CCR2—atherosclerosis	2.02e-05	0.000411	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—EDNRA—atherosclerosis	2.02e-05	0.000411	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—IGF2—atherosclerosis	2.01e-05	0.000411	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CYBA—atherosclerosis	2.01e-05	0.000409	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—PIK3CG—atherosclerosis	1.99e-05	0.000406	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PARP1—atherosclerosis	1.96e-05	0.000401	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—GHRL—atherosclerosis	1.96e-05	0.000401	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PLAT—atherosclerosis	1.96e-05	0.000401	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—APOB—atherosclerosis	1.96e-05	0.000399	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—CXCL8—atherosclerosis	1.94e-05	0.000396	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—EDN1—atherosclerosis	1.92e-05	0.000393	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—CCL5—atherosclerosis	1.91e-05	0.00039	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—F2—atherosclerosis	1.89e-05	0.000385	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—LPL—atherosclerosis	1.87e-05	0.000381	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—PRKCG—atherosclerosis	1.82e-05	0.00037	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—PIK3CG—atherosclerosis	1.81e-05	0.000368	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—SPP1—atherosclerosis	1.77e-05	0.000361	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—CXCL8—atherosclerosis	1.76e-05	0.000359	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.75e-05	0.000357	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—KNG1—atherosclerosis	1.72e-05	0.000352	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—AGTR1—atherosclerosis	1.71e-05	0.00035	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—CCL2—atherosclerosis	1.68e-05	0.000343	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PLG—atherosclerosis	1.67e-05	0.000341	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—LCAT—atherosclerosis	1.65e-05	0.000336	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—FABP4—atherosclerosis	1.65e-05	0.000336	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—PDGFB—atherosclerosis	1.64e-05	0.000334	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—APOA4—atherosclerosis	1.62e-05	0.000329	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—AGT—atherosclerosis	1.6e-05	0.000326	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.59e-05	0.000324	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—SOCS3—atherosclerosis	1.58e-05	0.000323	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—APOE—atherosclerosis	1.57e-05	0.000319	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—LEP—atherosclerosis	1.57e-05	0.000319	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—CAV1—atherosclerosis	1.55e-05	0.000316	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—APOA1—atherosclerosis	1.55e-05	0.000316	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—MMP3—atherosclerosis	1.53e-05	0.000312	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—IGF2—atherosclerosis	1.52e-05	0.00031	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—ESR1—atherosclerosis	1.49e-05	0.000305	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—APOB—atherosclerosis	1.48e-05	0.000301	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—F2—atherosclerosis	1.48e-05	0.000301	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.47e-05	0.000299	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—CXCL8—atherosclerosis	1.46e-05	0.000299	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—EDN1—atherosclerosis	1.45e-05	0.000296	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CCL5—atherosclerosis	1.44e-05	0.000294	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—PIK3CG—atherosclerosis	1.41e-05	0.000288	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—LPL—atherosclerosis	1.41e-05	0.000288	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.39e-05	0.000284	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—APOA2—atherosclerosis	1.39e-05	0.000284	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.39e-05	0.000284	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.39e-05	0.000284	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.37e-05	0.00028	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PRKCG—atherosclerosis	1.37e-05	0.00028	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—MAPK3—atherosclerosis	1.35e-05	0.000276	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—INS—atherosclerosis	1.34e-05	0.000273	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—SPP1—atherosclerosis	1.34e-05	0.000272	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—CXCL8—atherosclerosis	1.33e-05	0.000271	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—LPA—atherosclerosis	1.33e-05	0.000271	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—CCL2—atherosclerosis	1.32e-05	0.000268	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—IGF1—atherosclerosis	1.29e-05	0.000264	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—BGN—atherosclerosis	1.28e-05	0.000262	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—APOA5—atherosclerosis	1.27e-05	0.000259	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PDGFB—atherosclerosis	1.24e-05	0.000252	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—SERPINE1—atherosclerosis	1.23e-05	0.000251	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.22e-05	0.00025	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—AGT—atherosclerosis	1.21e-05	0.000246	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.18e-05	0.000241	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—APOE—atherosclerosis	1.18e-05	0.000241	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—LEP—atherosclerosis	1.18e-05	0.000241	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—NOS3—atherosclerosis	1.17e-05	0.000239	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CAV1—atherosclerosis	1.17e-05	0.000239	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—APOA1—atherosclerosis	1.17e-05	0.000238	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—ESR1—atherosclerosis	1.13e-05	0.00023	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—F2—atherosclerosis	1.11e-05	0.000227	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PIK3CG—atherosclerosis	1.07e-05	0.000218	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.06e-05	0.000216	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—LIPC—atherosclerosis	1.05e-05	0.000215	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—APOC3—atherosclerosis	1.05e-05	0.000214	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—LDLR—atherosclerosis	1.04e-05	0.000212	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—CXCL8—atherosclerosis	1.04e-05	0.000212	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—MAPK3—atherosclerosis	1.02e-05	0.000208	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CETP—atherosclerosis	1.02e-05	0.000207	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—INS—atherosclerosis	1.01e-05	0.000206	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—AKT1—atherosclerosis	1e-05	0.000205	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CCL2—atherosclerosis	9.93e-06	0.000203	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—IL6—atherosclerosis	9.89e-06	0.000202	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—IGF1—atherosclerosis	9.77e-06	0.000199	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—SCARB1—atherosclerosis	9.74e-06	0.000199	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—MMP9—atherosclerosis	9.41e-06	0.000192	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—NFKB1—atherosclerosis	9.31e-06	0.00019	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—SERPINE1—atherosclerosis	9.27e-06	0.000189	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—HMGCR—atherosclerosis	9.2e-06	0.000188	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—MAPK8—atherosclerosis	9.15e-06	0.000187	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—AKT1—atherosclerosis	9.13e-06	0.000186	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—NOS3—atherosclerosis	8.85e-06	0.000181	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—VEGFA—atherosclerosis	8.45e-06	0.000172	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—STAT3—atherosclerosis	8.37e-06	0.000171	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—ABCA1—atherosclerosis	8.2e-06	0.000167	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—MAPK3—atherosclerosis	7.99e-06	0.000163	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CXCL8—atherosclerosis	7.85e-06	0.00016	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—TGFB1—atherosclerosis	7.76e-06	0.000158	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—AKT1—atherosclerosis	7.59e-06	0.000155	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—IL6—atherosclerosis	7.47e-06	0.000152	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—MMP9—atherosclerosis	7.1e-06	0.000145	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—HMOX1—atherosclerosis	7.03e-06	0.000143	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—NFKB1—atherosclerosis	7.03e-06	0.000143	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—MAPK8—atherosclerosis	6.91e-06	0.000141	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—AKT1—atherosclerosis	6.89e-06	0.000141	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—APOB—atherosclerosis	6.74e-06	0.000137	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—GSTM1—atherosclerosis	6.55e-06	0.000134	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—LPL—atherosclerosis	6.43e-06	0.000131	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—VEGFA—atherosclerosis	6.38e-06	0.00013	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—STAT3—atherosclerosis	6.32e-06	0.000129	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—GPX1—atherosclerosis	6.27e-06	0.000128	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CD36—atherosclerosis	6.11e-06	0.000125	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—MAPK3—atherosclerosis	6.03e-06	0.000123	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—TGFB1—atherosclerosis	5.86e-06	0.000119	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—IL6—atherosclerosis	5.84e-06	0.000119	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—MTHFR—atherosclerosis	5.79e-06	0.000118	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PPARA—atherosclerosis	5.68e-06	0.000116	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—AGT—atherosclerosis	5.5e-06	0.000112	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—AKT1—atherosclerosis	5.39e-06	0.00011	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—APOE—atherosclerosis	5.39e-06	0.00011	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CAV1—atherosclerosis	5.34e-06	0.000109	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—APOA1—atherosclerosis	5.33e-06	0.000109	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PIK3CG—atherosclerosis	4.87e-06	9.92e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PPARG—atherosclerosis	4.7e-06	9.58e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—INS—atherosclerosis	4.61e-06	9.39e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—IL6—atherosclerosis	4.41e-06	9e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—ALB—atherosclerosis	4.22e-06	8.61e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—AKT1—atherosclerosis	4.07e-06	8.3e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—NOS3—atherosclerosis	4.04e-06	8.24e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PTGS2—atherosclerosis	3.69e-06	7.53e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—AKT1—atherosclerosis	1.86e-06	3.79e-05	CbGpPWpGaD
